Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Interdisciplinary Perspectives on Infectious Diseases|March 28, 2013
Changing Behavior among Nurses to Track Indwelling Urinary Catheters in Hospitalized PatientsBona Yoon, Samantha D McIntosh, Leslie Rodriguez, et al.
Journal of Healthcare Informatics Research|March 8, 2021
Understanding Demographic Risk Factors for Adverse Outcomes in COVID-19 Patients: Explanation of a Deep Learning ModelYijun Shao, Ali Ahmed, Angelike P Liappis, et al.
Journal of the American Medical Directors Association|June 24, 2018
Antimicrobial Stewardship in Long-Term Care Facilities: Approaches to Creating an Antibiogram when Few Bacterial Isolates Are Cultured AnnuallyMaria-Stephanie A Tolg, David M Dosa, Robin L P Jump, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|October 19, 2010
Exogenous procalcitonin evokes a pro-inflammatory cytokine responseAngelike P Liappis, Kevin W Gibbs, Eric S Nylen, et al.
AIDS (London, England)|September 10, 2002
Effect of delavirdine on plasma lipids and lipoproteins in patients receiving antiretroviral therapyAfsoon D Roberts, Angelike P Liappis, Chris Chinn, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 26, 2011
Present and past influences on current smoking among HIV-positive male veteransCarol A Reisen, Fernanda T Bianchi, Hannah Cohen-Blair, et al.
Atherosclerosis|June 12, 2009
Lipoprotein particle subclasses, cardiovascular disease and HIV infectionDaniel A Duprez, Lewis H Kuller, Russell Tracy, et al.
AIDS (London, England)|November 30, 2020
Losartan to reduce inflammation and fibrosis endpoints in HIV diseaseJason V Baker, Julian Wolfson, Gary Collins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2010
Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapyFiona C Lampe, Daniel A Duprez, Lewis H Kuller, et al.
AIDS Research and Human Retroviruses|March 22, 2021
Short Communication: A Pilot Study of the Effects of Losartan Versus Placebo on Pneumoproteins in HIV: A Secondary Analysis of a Randomized Double Blind StudyDavid M MacDonald, Gary Collins, Chris H Wendt, et al.
Pageof 3